Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

NCT00481871

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Chicago Hospital Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

NCT01527045

Conditions
Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

NCT00723099

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details
Completed

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00027820

Conditions
Adenocarcinoma, Adult Acute Myeloid Leukemia in Remission, Anemia, +72 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions